10 reports

Antisense & RNAi Therapeutics Market Size, Share &Trends Analysis Report By Route of Administration (Pulmonary Delivery, Intravenous Injection), By Application (CVDs, Oncology), By Technology, And Segment Forecasts, 2019 - 2025 The global antisense & RNAi therapeutics market size is expected to reach USD 1.81 billion...

  • Therapy
  • Antisense Technology
  • World

World Therapy Antisense Technology

  • Therapy
  • Antisense Technology
  • World
  • Gross Domestic Product Per Capita
  • Health Expenditure

World Drug Development Genomics Antisense Technology

  • Therapy
  • Cancer
  • Oncology
  • Pharmaceutical
  • Genomics
  • Antisense Technology
  • World
  • Health Provider Density

World Drug Development Genomics Antisense Technology

  • Therapy
  • Cancer
  • Pharmaceutical
  • Oncology
  • Genomics
  • Antisense Technology
  • World
  • Health Provider Density

World Gene Therapy Drug Development Antisense Technology Antiviral Cell Therapy Vaccine Genomics

  • Lung Cancer
  • Antiviral
  • Prostate Cancer
  • Blood Disease
  • Biotechnology
  • Biopharmaceutical
  • Dementia
  • Pharmaceutical
  • Gene Therapy
  • Ovarian Cancer
  • Antisense Technology
  • World
  • Mortality Rate
  • Drug Approval

Antisense Therapeutics Destum Partners Strongbridge Biopharma Australia Lead Price Therapy Antisense Technology Private Placement

  • Therapy
  • Antisense Technology
  • Neurological Disorder
  • Australia
  • Lead Price

Promethera Biosciences Immuron Study of Liver Diseases Isarna Therapeutics Hadassah Ciclofilin Pharmaceuticals Intercept Pharmaceuticals Dr. Falk Pharma Medarex Santaris CRYO-CELL International GENFIT Hadasit CTI Clinical Trial and Consulting Services UltiMAb World United States Drug Approval Health Provider Density Dropout Rate Digestive System Disorder Cell Therapy Monoclonal Antibody Genomics Musculoskeletal Disorder Antisense Technology

  • Therapy
  • Digestive System Disorder
  • Cell Therapy
  • Monoclonal Antibody
  • Genomics
  • Musculoskeletal Disorder
  • Antisense Technology
  • World
  • Drug Approval
  • Prescription Drug Sales

Immuron Study of Liver Diseases Ciclofilin Pharmaceuticals Intercept Pharmaceuticals Dr. Falk Pharma Santaris GENFIT World United States Drug Approval Health Provider Density Dropout Rate Digestive System Disorder Genomics Antisense Technology

  • Digestive System Disorder
  • Genomics
  • Antisense Technology
  • World
  • Drug Approval
  • Dropout Rate

World Texas Genomics Antisense Technology

  • Oncology
  • Pharmaceutical
  • Genomics
  • Antisense Technology
  • World
  • Life Expectancy
  • Health Provider Density

World Drug Development Monoclonal Antibody Antisense Technology Genomics

  • Oncology
  • Pharmaceutical
  • Genomics
  • Antisense Technology
  • World
  • Drug Approval